61%
Finnrick rating
#266 of 301 ranked vendors
11 of 26 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Coastal Peptides' purity-focus record is strongest in Tirzepatide, with Retatrutide showing a rebound after earlier purity misses. Semaglutide carries the clearest downside from severe identity/fill failures, while CJC-1295 is mixed; evidence is moderate but date-clustered, and traceability is limited by absent batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Coastal Peptides

Corporate and contact records show no verifiable operator, a fictitious address, and a new generic inbox paired with a geographically inconsistent phone number. The dossier also maps a telehealth funnel and a separate official-looking Coastal storefront with unresolved control.

27 pages8 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$12.60
79%
5
2
Retatrutide
$16.20
76%
5
3
Semaglutide
$12.60
48%
6
4
BPC-157
$4.95
48%
5
5
CJC-1295
$7.65
31%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%27 Feb 2025: 66%27 Feb 2025: 66%27 Feb 2025: 67%27 Feb 2025: 68%28 Feb 2025: 70%28 Feb 2025: 61%28 Feb 2025: 61%28 Feb 2025: 59%28 Feb 2025: 61%28 Feb 2025: 61%28 Feb 2025: 60%28 Feb 2025: 60%28 Feb 2025: 61%28 Feb 2025: 60%2 Mar 2025: 58%2 Mar 2025: 58%3 Mar 2025: 56%3 Mar 2025: 55%3 Mar 2025: 54%3 Mar 2025: 53%20 Mar 2025: 52%20 Mar 2025: 51%20 Mar 2025: 51%20 Mar 2025: 52%20 Mar 2025: 53%28 Mar 2025: 52%10 Aug 2026: current 61%66%61%Feb 25Aug 26
Coastal Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
28 Mar 2025Fail
Semaglutide
lab nameView COA
20 Mar 2025Pass
BPC-157
lab nameView COA
20 Mar 2025Pass
Retatrutide
lab nameView COA
20 Mar 2025Pass
Tirzepatide
lab nameView COA
20 Mar 2025Fail
CJC-1295 (No DAC)
lab nameView COA
20 Mar 2025Fail
Semaglutide
lab nameView COA
3 Mar 2025Fail
Semaglutide
lab nameView COA
3 Mar 2025Fail
BPC-157
lab nameView COA
3 Mar 2025Fail
BPC-157
lab nameView COA
3 Mar 2025Fail
Semaglutide
lab nameView COA
1-10 of 26

About Coastal Peptides test results from Finnrick

Coastal Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 26 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Coastal Peptides peptides in this dataset are Semaglutide (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 26 recent tests.

Corrections
No corrections.